In Brief: A 16-Hour Ritalin October 3, 2019 Chris Aiken, MD From The Carlat Psychiatry Report Issue Links: Learning Objectives | Editorial Information | PDF of Issue Adhansia XR is a new extended-release methylphenidate. Its distinguishing feature is its 16-hour duration.Read More
General PsychiatryKarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change EverythingRead More
Child PsychiatryHelping Kids Feel Safe: Talking About School Shootings A teen is using substances—how do you decide what kind of treatment makes sense? Outpatient therapy? A more structured program? We’re breaking it down.Listen now
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
